News
21h
Zacks Investment Research on MSNCVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
StockStory.org on MSN18h
CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy InnovationDiversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.
Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...
The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...
CVS Health (CVS) closed the most recent ... and the technology-dominated Nasdaq saw a decrease of 3.07%. The the stock of drugstore chain and pharmacy benefits manager has risen by 2% in the ...
In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp ...
Today, leaders from CVS Health® (NYSE: CVS) were joined by state and local representatives to celebrate the reopening of one of its Hendersonville CVS Pharmacy stores. Located at 522 South Main ...
Shares of CVS Health jumped after the company reported a strong first quarter and agreed to open up access to Novo Nordisk's weight-loss medication at more affordable prices. The stock was up 8.7% at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results